| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Crysvita 20 mg/mL injection, 1 mL vial |
has Australian BoSS |
True |
burosumab |
Inferred relationship |
Some |
975181551 |
| Crysvita 20 mg/mL injection, 1 mL vial |
has intended active ingredient |
True |
burosumab |
Inferred relationship |
Some |
975181551 |
| burosumab |
has intended active ingredient |
True |
burosumab |
Inferred relationship |
Some |
516790142 |
| burosumab 20 mg/mL injection, vial |
has Australian BoSS |
True |
burosumab |
Inferred relationship |
Some |
899970859 |
| burosumab 20 mg/mL injection, vial |
has intended active ingredient |
True |
burosumab |
Inferred relationship |
Some |
899970859 |
| Crysvita 30 mg/mL injection, 1 mL vial |
has Australian BoSS |
True |
burosumab |
Inferred relationship |
Some |
2011305934 |
| Crysvita 30 mg/mL injection, 1 mL vial |
has intended active ingredient |
True |
burosumab |
Inferred relationship |
Some |
2011305934 |
| burosumab 10 mg/mL injection, vial |
has Australian BoSS |
True |
burosumab |
Inferred relationship |
Some |
1336255052 |
| burosumab 10 mg/mL injection, vial |
has intended active ingredient |
True |
burosumab |
Inferred relationship |
Some |
1336255052 |
| Crysvita 10 mg/mL injection, 1 mL vial |
has Australian BoSS |
True |
burosumab |
Inferred relationship |
Some |
2142364504 |
| Crysvita 10 mg/mL injection, 1 mL vial |
has intended active ingredient |
True |
burosumab |
Inferred relationship |
Some |
2142364504 |
| burosumab 30 mg/mL injection, vial |
has Australian BoSS |
True |
burosumab |
Inferred relationship |
Some |
1589391318 |
| burosumab 30 mg/mL injection, vial |
has intended active ingredient |
True |
burosumab |
Inferred relationship |
Some |
1589391318 |